Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex

Area of Science:

• Molecular Biology
• Structural Biology
• Pharmacology

Background:

• Thalidomide teratogenicity is linked to the degradation of the SALL4 embryonic transcription factor.
• The CRL4^CRBN E3 ubiquitin ligase complex mediates this degradation.

Purpose of the Study:

• To elucidate the molecular mechanism of SALL4 recruitment by CRL4^CRBN in the presence of thalidomide analogs.
• To identify structural features enabling rational drug design for reduced teratogenic risk.

Main Methods:

• X-ray crystallography was used to determine the structure of SALL4's zinc finger in complex with pomalidomide, cereblon, and DDB1.
• Comparative analysis of binding interactions was performed.

Main Results:

• The study reveals the structural basis for the recruitment of SALL4 by the cereblon-CRBN complex.
• Differences in binding position and sequence compared to Ikaros were identified.

Conclusions:

• The molecular details of SALL4 recruitment by CRL4^CRBN provide insight into thalidomide's teratogenic mechanism.
• Targeting these interactions offers a strategy for designing safer cereblon-binding drugs with minimized teratogenic potential.